APAudrey Flak Pennington

Audrey Flak Pennington

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Audrey Flak Pennington has a total of 94 co-authors. Here are the top co-authors by number of shared publications:

  • Maria C. Mirabelli

    Asthma and Air Quality Branch, Division of Environmental Health Science and Practice, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia

    4 shared publications
  • Joy Hsu

    Asthma and Community Health Branch, Division of Environmental Health Science and Practice, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, USA

    3 shared publications
  • Kanta Sircar

    Asthma and Community Health Branch, Division of Environmental Health Science and Practice, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, USA

    3 shared publications
  • Kanta Sircar

    Asthma and Community Health Branch, Division of Environmental Health Science and Practice, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, USA

    3 shared publications
  • Maria C. Mirabelli

    Asthma and Community Health Branch, Division of Environmental Health Science and Practice, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, USA

    3 shared publications
  • Mitchel Klein

    From the Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, GA

    3 shared publications

Latest Publications

  • Open Access

    Association Between Low-Level Lead Exposure and Serum Gamma-Glutamyl Transferase Concentrations as a Biomarker of Oxidative Stress in U.S. Adolescents Aged 12–19 Years

    by Wenping Hu, Tanya T. LeBlanc, Audrey F. Pennington, Cheryl R. Cornwell, Paul B. Allwood

    Objectives: This study aims to investigate the potential relationship between low-level lead exposure and serum gamma-glutamyl transferase (GGT) concentrations, which may serve as a biomarker of oxidative stress in U.S. adolescents. Methods: We used NHANES data from 1999 to 2000 to 2017–2018. Analyses were limited to adolescents aged 12–19 years with blood lead levels (BLLs) below 5 µg/dL (n = 11,978). BLLs were categorized into either two groups based on the median BLL (i.e., p < 0.001). The multivariable linear regression analysis indicated that, after adjusting for potential confounding factors, natural log-transformed serum GGT concentrations were higher among adolescents in BLL quartile 4 compared to those in BLL quartile 1 (β-coefficient = 0.0607; 95% CI: 0.0306, 0.0908). However, no significant associations were observed between BLLs and serum GGT concentrations among adolescents in BLL quartiles 2 and 3 when compared to quartile 1. Conclusions: In the present study, we observed that higher BLLs were associated with higher serum GGT concentrations in U.S. adolescents aged 12–19 years. Further research is needed to substantiate the positive relationship between BLLs and serum GGT and explore the mechanisms underlying their interaction with oxidative stress in adolescents.


  • Awareness of wildfire smoke among U.S. adults with and without asthma

    by Maria C. Mirabelli, Tia C. Dowling, Lauren Freelander, Audrey F. Pennington, Scott A. Damon

    To describe awareness of ambient wildfire smoke among U.S. adults with and without asthma. We analyzed data from the summer wave of the 2021 ConsumerStyles survey, a nationally representative survey of 4085 U.S. adults. Respondents self-reported their asthma status and awareness of wildfire smoke where they lived in the past 12 months. We linked survey responses by zip code of residence with satellite-detected wildfire smoke plume data that estimated the daily maximum smoke plume density over the preceding year. We estimated associations between asthma status and awareness of wildfire smoke across categories of maximum smoke plume density and days with medium- or heavy-density smoke as prevalence ratios (PRs) with 95% confidence intervals (CIs) using predicted marginal probabilities from logistic regression models. Over 98% of the estimated population of U.S. adults lived in a zip code affected by ≥1 day of medium- or heavy-density wildfire smoke, which occurred on an average of 16 days in the past year. Awareness of wildfire smoke was reported by 19% of U.S. adults and was higher among adults with than without asthma (PR: 1.25; 95% CI: 1.01, 1.55), including in zip codes affected by heavy-density smoke (PR: 1.30, 95% CI: 1.04, 1.63) and with 22 or more days of medium- to heavy-density smoke (PR: 1.22, 95% CI: 1.01, 1.47). Although awareness of wildfire smoke was higher among U.S. adults with than without asthma, low percentages of awareness overall indicate a need for health communication about wildfire smoke and its health risks.


  • Electric vehicles and health: A scoping review

    by Audrey F. Pennington, Cheryl R. Cornwell, Kanta Devi Sircar, Maria C. Mirabelli


  • Assessing the relationship between cyanobacterial blooms and respiratory-related hospital visits: Green bay, Wisconsin 2017–2019

    by Jordan F. Murray, Amy M. Lavery, Blake A. Schaeffer, Bridget N. Seegers, Audrey F. Pennington, Elizabeth D. Hilborn, Savannah Boerger, Jennifer D. Runkle, Keith Loftin, Jennifer Graham, et al.


  • Large-scale agricultural burning and cardiorespiratory emergency department visits in the U.S. state of Kansas

    by Audrey F. Pennington, Ambarish Vaidyanathan, Farah S. Ahmed, Arie Manangan, Maria C. Mirabelli, Kanta Devi Sircar, Fuyuen Yip, W. Dana Flanders

    Background Prescribed agricultural burning is a common land management practice, but little is known about the health effects from the resulting smoke exposure. Objective To examine the association between smoke from prescribed burning and cardiorespiratory outcomes in the U.S. state of Kansas. Methods We analyzed a zip code-level, daily time series of primary cardiorespiratory emergency department (ED) visits for February–May (months when prescribed burning is common in Kansas) in the years 2009–2011 (n = 109,220). Given limited monitoring data, we formulated a measure of smoke exposure using non-traditional datasets, including fire radiative power and locational attributes from remote sensing data sources. We then assigned a population-weighted potential smoke impact factor (PSIF) to each zip code, based on fire intensity, smoke transport, and fire proximity. We used Poisson generalized linear models to estimate the association between PSIF on the same day and in the past 3 days and asthma, respiratory including asthma, and cardiovascular ED visits. Results During the study period, prescribed burning took place on approximately 8 million acres in Kansas. Same-day PSIF was associated with a 7% increase in the rate of asthma ED visits when adjusting for month, year, zip code, meteorology, day of week, holidays, and correlation within zip codes (rate ratio [RR]: 1.07; 95% confidence interval [CI]: 1.01, 1.13). Same-day PSIF was not associated with a combined outcome of respiratory ED visits (RR [95% CI]: 0.99 [0.97, 1.02]), or cardiovascular ED visits (RR [95% CI]: 1.01 [0.98, 1.04]). There was no consistent association between PSIF during the past 3 days and any of the outcomes. Significance These results suggest an association between smoke exposure and asthma ED visits on the same day. Elucidating these associations will help guide public health programs that address population-level exposure to smoke from prescribed burning.


  • Clinical outcomes among hospitalized US adults with asthma or chronic obstructive pulmonary disease, with or without COVID-19

    by Cheryl R. Cornwell, Joy Hsu, Lindsay K. Tompkins, Audrey F. Pennington, W. Dana Flanders, Kanta Sircar

    Objective This study assesses the risk of severe clinical outcomes during hospitalizations of adults with asthma and/or COPD plus COVID-19 and compares those risks with those during hospitalizations of adults with asthma and/or COPD without COVID-19. Methods We used data from 877 U.S. hospitals from the Premier Healthcare Database during March 2020-March 2021. Hospitalizations (n = 311,215) among patients aged >= 18 years with an ICD-10-CM diagnosis involving asthma or COPD were classified into three groups: adults with asthma (but not COPD), adults with COPD (but not asthma), and adults with both asthma and COPD. We used multivariable Poisson regression to assess associations of severe clinical outcomes [intensive care unit (ICU) admission, use of invasive mechanical ventilation (IMV), and death] and COVID-19 status. Results The percentage of hospitalizations among patients with asthma and COVID-19 resulting in ICU admission, IMV, and death were 46.9%, 14.0%, and 8.0%, respectively. These risks were higher than those among patients with asthma without COVID-19 (adjusted risk ratio [aRR], 1.17 [95% confidence interval (CI), 1.14-1.21], 1.61 [95% CI, 1.50-1.73], and 5.56 [95% CI, 4.89-6.32]), respectively. Risks of ICU admission, IMV, and death were also high among patients with COPD and COVID-19 and exceeded the corresponding risks among patients with COPD without COVID-19. Conclusion Hospitalizations among patients with asthma and/or COPD with COVID-19 had a more severe clinical course than hospitalizations for asthma and/or COPD exacerbations without COVID-19. Supplemental data for this article is available online at at www.tandfonline.com/ijas .


  • Wildfire smoke and symptoms affecting mental health among adults in the U.S. state of Oregon

    by Maria C. Mirabelli, Ambarish Vaidyanathan, Audrey F. Pennington, Dongni Ye, Carol A. Trenga


  • Open Access

    Communication channels for receiving air quality alerts among adults in the United States

    by Lindsay K. Tompkins, Audrey F. Pennington, Kanta D. Sircar, Maria C. Mirabelli


  • Open Access

    Risk of Clinical Severity by Age and Race/Ethnicity Among Adults Hospitalized for COVID-19—United States, March–September 2020

    by Audrey F Pennington, Lyudmyla Kompaniyets, April D Summers, Melissa L Danielson, Alyson B Goodman, Jennifer R Chevinsky, Leigh Ellyn Preston, Lyna Z Schieber, Gonza Namulanda, Joseph Courtney, et al.

    Background: Older adults and people from certain racial and ethnic groups are disproportionately represented in coronavirus disease 2019 (COVID-19) hospitalizations and deaths. Methods: Using data from the Premier Healthcare Database on 181 813 hospitalized adults diagnosed with COVID-19 during March–September 2020, we applied multivariable log-binomial regression to assess the associations between age and race/ethnicity and COVID-19 clinical severity (intensive care unit [ICU] admission, invasive mechanical ventilation [IMV], and death) and to determine whether the impact of age on clinical severity differs by race/ethnicity. Results: Overall, 84 497 (47%) patients were admitted to the ICU, 29 078 (16%) received IMV, and 27 864 (15%) died in the hospital. Increased age was strongly associated with clinical severity when controlling for underlying medical conditions and other covariates; the strength of this association differed by race/ethnicity. Compared with non-Hispanic White patients, risk of death was lower among non-Hispanic Black patients (adjusted risk ratio, 0.96; 95% CI, 0.92–0.99) and higher among Hispanic/Latino patients (risk ratio [RR], 1.15; 95% CI, 1.09–1.20), non-Hispanic Asian patients (RR, 1.16; 95% CI, 1.09–1.23), and patients of other racial and ethnic groups (RR, 1.13; 95% CI, 1.06–1.21). Risk of ICU admission and risk of IMV were elevated among some racial and ethnic groups. Conclusions: These results indicate that age is a driver of poor outcomes among hospitalized persons with COVID-19. Additionally, clinical severity may be elevated among patients of some racial and ethnic minority groups. Public health strategies to reduce severe acute respiratory syndrome coronavirus 2 infection rates among older adults and racial and ethnic minorities are essential to reduce poor outcomes.


  • Uncontrolled asthma and household environmental exposures in Puerto Rico

    by Kristen N. Cowan, Xiaoting Qin, Krystel Ruiz Serrano, Kanta Sircar, Audrey F. Pennington

    Objective: To describe asthma control and household environmental exposures among adults and children with asthma in Puerto Rico. Methods: A cross-sectional analysis was conducted using data from the 2014–2016 Behavioral Risk Factor Surveillance System Asthma Call-back Survey on 931 adults and 177 children with current asthma in Puerto Rico. These data were analyzed to assess the prevalence of uncontrolled asthma in Puerto Rico and potential associations with household environmental exposure to cockroaches, smoke, and mold. Asthma control was classified using daytime and nighttime symptoms, activity limitation, and short-acting beta agonist use. Prevalence and prevalence ratios were calculated, adjusting for sample weighting. Results: An estimated 53% of adults with asthma and 29% of children with asthma in Puerto Rico have uncontrolled asthma. Among adults with asthma, in the past 30 days, 29% had seen or smelled mold and 50% had seen cockroaches; in the past week, 12% reported having someone smoke in their home. Adults with uncontrolled asthma were 1.4 times more likely to have observed mold in their homes than were those with controlled asthma when adjusting for age, sex, education, and income (prevalence ratio [95% confidence interval]: 1.4 [1.1, 1.8]). Children with uncontrolled asthma were also more likely to have mold observed in their home than were children with controlled asthma (adjusted PR[95% CI]: 3.0 [1.3, 7.1]). Conclusions: Uncontrolled asthma is common among adults and children with asthma in Puerto Rico. These results suggest potential differences in household mold exposure by asthma control status.